期刊文献+

美托洛尔与阿托伐他汀治疗老年不稳定心绞痛的效果观察 被引量:1

Effect observation of metoprolol and atorvastatin on the elderly patients with unstable angina pectoris
下载PDF
导出
摘要 目的:探讨美托洛尔与阿托伐他汀治疗老年不稳定心绞痛的临床疗效。方法:收治老年不稳定心绞痛患者36例,随机分为两组。对照组给予阿托伐他汀治疗,试验组给予美托洛尔和阿托伐他汀联合治疗,比较两组临床疗效、心绞痛发作情况以及心功能指标。结果:试验组总有效率94.44%,对照组总有效率55.56%,试验组总有效率高于对照组,差异有统计学意义(P<0.05)。与试验组相比,对照组心绞痛发作时间较长、发作频率较高,SV值和EF值较低,差异有统计学意义(P<0.05)。结论:美托洛尔和阿托伐他汀联合治疗老年不稳定心绞痛患者的临床疗效显著,可明显改善患者的心绞痛情况。 Objective:To investigate the clinical effect of metoprolol and atorvastatin in the treatment of elderly patients with unstable angina pectoris.Methods:36 cases of elderly patients with unstable angina pectoris were divided into two groups randomly.The control group was treated with atorvastatin,and the experiment group was treated with metoprolol and atorvastatin.The clinical effect,angina pectoris and cardiac function were compared between groups.Results:The total effective rate of the experiment group was 94.44%,and the total effective rate of the control group was 55.56%.The total effective rate of the experiment group was higher than that of the control group,and the difference was statistically significant(P<0.05).Compared with the experiment group,the control group had longer attack time,higher seizure frequency,lower SV value and EF value,and the difference was statistically significant(P<0.05).Conclusion:Metoprolol combined with atorvastatin in the treatment of elderly patients with unstable angina pectoris had significant clinical effect,and could improve the angina pectoris significantly.
作者 郭雪萍 Guo Xueping(Luoyang Fourth Military Cadre Retreat of Military Region in Henan Province,471000)
出处 《中国社区医师》 2018年第21期26-26,28,共2页 Chinese Community Doctors
关键词 美托洛尔 阿托伐他汀 不稳定心绞痛 Metoprolol Atorvastatin Unstable angina pectoris
  • 相关文献

参考文献6

二级参考文献60

  • 1邵玲.阿托伐他汀对不稳定型心绞痛老年患者疗效及内皮功能的影响[J].中国动脉硬化杂志,2015,23(3):304-306. 被引量:19
  • 2李慧颖,李静.阿托伐他汀对高血压病早期肾损害患者MMP-9及TIMP-1的影响[J].中国动脉硬化杂志,2015,23(6):607-612. 被引量:6
  • 3赵水平.氨氯地平的降压外作用及意义[J].高血压杂志,2005,13(2):67-69. 被引量:20
  • 4Solanki TB,Shah PA,Patel KG.Central composite design for validation of HPTLC method for simultaneous estimationof olmesartan medoxomil,amlodipine besylateand hydrochlorothiazide in tablets[J].Indian J Pharm Sci,2014,76(3):179-187.
  • 5Pusapati RT,Kumar MK,Rapeti SS,et al.Development of coprocessed excipients in the design and evaluation of atorvastatin calcium tablets by direct compression method[J].Int J Pharm Investig,2014,4(2):102-106.
  • 6Pugazhenthan T,Singh H,Kumar P,et al.Is Dysguesia going to be a rare or a common side-effect of amlodipine[J].Ann Med Health Sci Res,2014,4(1):43-44.
  • 7Pitt B,Byington RP,Furberg CD,et al.Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events PREVENT Investigators[J].Clirculation,2000,102(13):1503-1510.
  • 8Deanfield JE,Detry JM,Lichtlen PR,et al.Amlodipine reducestransient myocardial ischemia in patients with coronary arterydisease:double-blind Circadian Anti-Ischemia Program in Europe(CAPE Trial)[J].J Am Coll Cardiol,1994,24(6):1460-1467.
  • 9Liao JK. Isoprenoids as mediators of the biological effects of statins. J Clin Invest, 2002, 110: 285-288.
  • 10Omori H, Nagashima H, Tsurumi Y, et al. Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects. Br J Clin Pharmacol, 2002, 54: 395-399.

共引文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部